SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (24906)8/26/1998 9:00:00 PM
From: RXGOLF  Respond to of 32384
 
<<I talked to Ligand IR and SRGN has responded back to the FDA. They are awaiting FDA response>>

Thanks for the update! We will see if after missing the dunk, maybe we can get a quick tip in :-). Would you guess that LGND worked with SRGN on this effort, or was it solo. The experience could prove useful as the LGND pipeline develops more compounds from IND to NDA to the pharmacy shelves.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News